Company Performance: Revenue, earnings, and profit margins directly influence investor confidence. Positive financial reports often drive the stock price up, while poor results can lead to a decline.

Industry Trends: The overall health and growth prospects of the biotech sector impact NKGN.US. Positive industry news, technological advancements, or increased funding can benefit the stock.

Regulatory Environment: Government regulations and policies related to drug development, approvals, and healthcare affect the company's operations and profitability, thus influencing the stock price.

Clinical Trial Results: The success or failure of clinical trials for NKGN.US's drug candidates is a major factor. Positive trial outcomes typically boost the stock, while negative results can cause it to plummet.

Market Sentiment: General investor optimism or pessimism towards the stock market and biotech stocks can influence NKGN.US's price, regardless of its specific performance.

Competition: The competitive landscape within the biotech industry, including the emergence of new treatments or rival companies, can impact NKGN.US's market share and stock value.

News and Announcements: Press releases, media coverage, and company announcements regarding partnerships, acquisitions, or new product developments can significantly move the stock price.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth can influence investor sentiment and affect the overall stock market, including NKGN.US.

Analyst Ratings: Recommendations and price targets from financial analysts can influence investor perception and trading activity, thereby affecting the stock price.

Investor Confidence: Overall trust and belief in the company's management, strategy, and future prospects are crucial determinants of stock price.